Tweetovi

Blokirali ste korisnika/cu @HarvardMIT_CRS

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @HarvardMIT_CRS

  1. Prikvačeni tweet

    The fellows showcase is starting! Center co-director introduces the session

    Prikaži ovu nit
    Poništi
  2. 3. velj

    Wai Cheung (Adrian) Chan, student in Chemical Biology PhD Program saves the day for with a more biology-oriented talk on DUBs and the development of a chemoproteomic platform that could lead to discovery of new DUB inhibitors and novel therapeutic opportunities!

    Prikaži ovu nit
    Poništi
  3. 3. velj

    PhD student at T.H. Chan Harvard School of Public Health is discussing factorial clinical trial designs and potential applications

    Prikaži ovu nit
    Poništi
  4. 3. velj

    PhD candidate in Health Policy Pragya Kakani discussing the safety and efficacy of off-label uses of cancer medicines in the US

    Prikaži ovu nit
    Poništi
  5. 3. velj

    Unique study led by Caroline Marra PhD student in Health Policy Management on foundation-industry collaborations in clinical research and understanding the innovation effects

    Prikaži ovu nit
    Poništi
  6. 3. velj

    Super interesting talk from Shawn Kim student on how to use data visualization & statistical methods to enhance operational efficiency of new patient screening

    Prikaži ovu nit
    Poništi
  7. 3. velj

    Richard Huang, pathologist talking about the future of Digital Pathology in the context of , and implications for regulations

    Prikaži ovu nit
    Poništi
  8. Great morning at Regsci Doctoral Student Symp! Great research around RCT design shortcomings, methods extrapolating patient level data, and FDA precert & digital pathology Thanks students and faculty

    Poništi
  9. 3. velj

    Always blown away by the quality and diversity of student & fellow research. Thanks again to and for sponsoring & hosting! – mjesto: Harvard Business School

    Poništi
  10. 3. velj

    MD PhD student presenting a very compelling argument for sharing individual patient data from clinical trials and how we can learn why some trials have failed and predict future outcomes

    Prikaži ovu nit
    Poništi
  11. NEW op-ed with in Perspective: Why we should be wary of an aggressive government response to coronavirus

    Poništi
  12. 3. velj

    Great discussion around the study lead by on how to enrich the methods and extend the scope from faculty and faculty

    Prikaži ovu nit
    Poništi
  13. 3. velj

    Fascinating talk by Health Policy PhD candidate on inadequacies in RCTs and consequences on knowledge gained and costs for society

    Prikaži ovu nit
    Poništi
  14. 3. velj

    Regsci Fellowship Director provides intro of , including Regsci Fellowship program and a shout out to our fantastic fellows

    Prikaži ovu nit
    Poništi
  15. 3. velj

    Starting now: Regulatory Science Student Symposium 2020! CRS Faculty and enthusiastic mentor welcomes us all

    Prikaži ovu nit
    Poništi
  16. 2. velj

    Happening tomorrow: Regulatory Science Student Symposium 2020 , Industry Seminar: Dan Svirsky, , Cambridge: CyTOF Mass Cytometry Workshop Series , and Taxes for Artists :

    Poništi
  17. Happy ! Today we spotlight another terrific fellow, ! Dr. Russo completed his PhD from and works with Dr. at

    Poništi
  18. Great 10 minute ⚡ talks from all! If you are interested in joining the team as a fellow, you're in luck! More info here:

    Prikaži ovu nit
    Poništi
  19. . fellow presents work on the incorporation of external data into clinical trials, including the potential for platform trials that share a single external control arm

    Prikaži ovu nit
    Poništi
  20. . fellow and collaborator presents recent work comparing and approval data for biosimilars, based on work published in :

    Prikaži ovu nit
    Poništi
  21. Dr. Kevin Nam, researcher and collaborator, presents his collaborative work on the "Dynamic Dossier in the Cloud"

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·